Sarcopenia is a geriatric syndrome with a significant impact on older patients' quality of life,
morbidity and mortality. Despite the new available criteria, its early diagnosis remains …

Myostatin is a member of the transforming growth factor (TGF)-β superfamily. It is expressed
by animal and human skeletal muscle cells where it limits muscle growth and promotes …

Sarcopenia is common in hemodialysis patients, especially in the elderly patients
undergoing hemodialysis. Various factors may contribute to the occurrence of sarcopenia …

Background Myostatin and activin A induce muscle wasting by activating the ubiquitin
proteasome system and inhibiting the Akt/mammalian target of rapamycin pathway. In …

Protein Energy Wasting (PEW) in hemodialysis (HD) patients is a multifactorial condition due
to specific pathology-related pathogenetic mechanisms, leading to loss of skeletal muscle …

Chronic kidney disease (CKD) is linked to an elevated risk of malnutrition and sarcopenia,
contributing to the intricate network of CKD-related metabolic disorders. Adipokines and …

Background Chronic kidney disease (CKD) is a progressive systemic condition
characterized by numerous complications. Among these, alterations in skeletal muscle …

Physical inactivity is considered a significant risk factor for mortality and morbidity among
chronic hemodialysis (HD) patients. Therefore, physical exercise is recommended in the …

Aim Sarcopenia is reportedly associated with a poor prognosis in patients who undergo
living‐donor liver transplantation (LDLT), most of whom are not able to tolerate muscle …

Objective: Myostatin, which is known as a negative skeleton muscle regulator, is associated
with mortality in maintenance hemodialysis patients. However, the significance of serum …